Grisha Alroi-Arloser, CEO of the German-Israeli Chamber of Industry and Commerce, looks back on how Israel weathered the corona pandemic and considers what the future holds for the long-established international partnership between his nation and Germany.
2020 was the year Germany went all in on hydrogen as a key to its transition to the clean energy of future. We spoke with the German government’s commissioner for green hydrogen, Stefan Kaufmann, about where Germany is coming from and where it’s headed.
Interview with Michael Hüther: The director of the German Economic Institute in Cologne, considers Germany’s response to the corona crisis and the direction the economy will take.
Interview with Thomas Jarzombek, the Ministry for Economic Affairs’ commissioner for the digital industry and start-ups.
Looking for some reliable economic prognostication? The Hamburg Institute of International Economics (HWWI) should be on your list of places to consult.
Markets Germany had the chance to put a number of questions about hydrogen to Armin Schnettler, CEO of New Energy Business at Siemens Energy, who sees bright things ahead for H2 in Germany and elsewhere.
Jochen Homann is the president of the Bundesnetzagentur, the national agency responsible for regulating, among other things, Germany’s telecommunications industry. He talks to Markets Germany about the opportunities and challenges presented by 5G.
Germans have a reputation for being scientific but rather humorless. But is this cultural stereotype true? Fiona Evans, U.S. consul general in Düsseldorf, considers the relationship between her countrymen and their German business partners.
Interview with Joachim Damasky, managing director at the German Association of the Automotive Industry (VDA). The association represents about 600 companies, including VW, BMW and Daimler.
With the entire world looking for responses to the coronavirus pandemic, Germany’s pharmaceutical companies are attracting considerable attention. We asked Han Steutel, the president of the German Association of Research-Based Pharmaceutical Companies, for an update on the progress in developing anti-corona medications.
